Acceptance rate | 46% |
---|---|
Time to first decision | 6 months* |
Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
Acta Pharmaceutica Sciencia is an official peer-reviewed scientific journal dedicated to the advancement of pharmaceutical sciences. The journal serves as an open access platform for the publication of high-quality, interdisciplinary research across all areas of pharmacy and pharmaceutical sciences.
The journal publishes original research articles and invited review papers that demonstrate conceptual novelty and scientific rigor. Areas of interest include, but are not limited to, the following:
- Drug design, discovery, and development
- Pharmacology and pharmacokinetics
- Pharmaceutical technology and drug delivery systems
- Pharmaceutical chemistry and analysis
- Pharmacognosy and phytochemistry
- Clinical and hospital pharmacy
- Regulatory sciences and pharmaceutical biotechnology
Submissions that are not aligned with pharmaceutical relevance may be declined without external review. Review articles are typically considered by invitation or prior agreement with the editors.
Acta Pharmaceutica Sciencia is published quarterly, accepts manuscripts exclusively in English, and adheres to rigorous editorial policies, including double-blind peer review by at least two independent experts. The journal complies with international ethical standards, including those outlined by the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), and the European Association of Science Editors (EASE), and fully observes the Principles of Transparency and Best Practice in Scholarly Publishing.
There are no processing or publication charges. All accepted articles are made freely accessible on the journal’s website, ensuring broad dissemination of scientific knowledge without financial barriers. Authors are required to submit manuscripts via the online submission system available at www.actapharmsci.com.
The editorial board, publisher, and affiliated institutions do not assume responsibility for the views and statements expressed in published articles. Authors are solely accountable for the content of their work. The journal retains international copyright for all published materials.